5.22
+0.045(+0.87%)
Currency In USD
| Previous Close | 5.17 |
| Open | 5.05 |
| Day High | 5.27 |
| Day Low | 5.05 |
| 52-Week High | 10.48 |
| 52-Week Low | 1.6 |
| Volume | 47,804 |
| Average Volume | 2.3M |
| Market Cap | 178.98M |
| PE | -1.98 |
| EPS | -2.64 |
| Moving Average 50 Days | 3.36 |
| Moving Average 200 Days | 2.76 |
| Change | 0.05 |
If you invested $1000 in Protara Therapeutics, Inc. (TARA) 10 years ago, it would be worth $13.28 as of December 26, 2024 at a share price of $5.215. Whereas If you bought $1000 worth of Protara Therapeutics, Inc. (TARA) shares 5 years ago, it would be worth $395.08 as of December 26, 2024 at a share price of $5.215.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Protara Announces Closing of $100 Million Public Offering
GlobeNewswire Inc.
Dec 11, 2024 9:05 PM GMT
NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the closing of its underwritten publi
Protara Announces Pricing of $100 Million Public Offering
GlobeNewswire Inc.
Dec 10, 2024 4:35 AM GMT
NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the pricing of its underw
Protara Announces Proposed Public Offering
GlobeNewswire Inc.
Dec 09, 2024 9:01 PM GMT
NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that it has commenced an